{"title":"Rethinking Rheumatoid Arthritis Performance Measures in the Context of Meaningful Clinical Outcomes.","authors":"Sharika G Menon, Beverly K Johnson","doi":"10.3899/jrheum.2026-0887","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0887","url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeffrey B Driban, Matthew S Harkey, Shao-Hsien Liu, Kate L Lapane, Jonggyu Baek, Julieann C Patarini, Timothy E McAlindon, Stephenie C Lemon, Adrian H Zai, Leigh F Callahan, Alison H Chang, Jamie E Collins, Charles B Eaton, Marc C Hochberg, C Kent Kwoh, Gayle E Lester, John A Lynch, Charles E McCulloch, Michael C Nevitt, Susan Rubin, Erika Schneider, Michelle S Yau, Grace H Lo
{"title":"Maximizing the utilization and impact of the Osteoarthritis Initiative (OAI): A comprehensive guide to data handling and analytic strategies.","authors":"Jeffrey B Driban, Matthew S Harkey, Shao-Hsien Liu, Kate L Lapane, Jonggyu Baek, Julieann C Patarini, Timothy E McAlindon, Stephenie C Lemon, Adrian H Zai, Leigh F Callahan, Alison H Chang, Jamie E Collins, Charles B Eaton, Marc C Hochberg, C Kent Kwoh, Gayle E Lester, John A Lynch, Charles E McCulloch, Michael C Nevitt, Susan Rubin, Erika Schneider, Michelle S Yau, Grace H Lo","doi":"10.3899/jrheum.2026-0551","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0551","url":null,"abstract":"<p><p>The Osteoarthritis Initiative (OAI) is a cohort study with publicly available resources intended to accelerate osteoarthritis research by providing harmonized clinical data, imaging, and biospecimens for 4,796 participants aged 45-79 years at enrollment, who were followed longitudinally for up to 16 years. OAI resources are distributed across three repositories: 1) the National Institute of Mental Health Data Archive (NDA; original visit data, millions of images, secondary image assessment, and biospecimen project data), 2) the database of Genotypes and Phenotypes (dbGaP; genome-wide association study data), and 3) the OAI biospecimen repository. The breadth and depth of the OAI's complex data architecture - spanning multiple repositories, nested studies, and longitudinal data files - are strengths. However, they also present challenges for investigators, particularly those new to the OAI. This manuscript provides a practical, methods-oriented guide to using OAI data and resources to lower barriers to OAI use, with the hope of accelerating discovery in osteoarthritis and related fields. We describe the study's design and its three repositories. We offer detailed guidance on dataset structure, file formats, naming conventions, key-merging variables, and missing-data codes. We address common analytic considerations, including the handling of data from image assessment projects, contingent variables, informative missingness, and subcohort-specific eligibility criteria. We provide recommendations for transparent reporting and reproducibility. We also describe how the OAI Collaborative Osteoarthritis Research Enterprise (OAI CORE) Knowledgebase, a National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)-funded initiative designed to promote and facilitate the use of OAI resources, can assist users.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Theo Wirth, Lisa Diebold, Nathalie Balandraud, Emilie Fockens, Sophie Trijau, Pierre Lafforgue, Thao Pham
{"title":"Rate of Requests to Return to Intravenous Biologic Disease-Modifying Antirheumatic Drug Therapy After an Intravenous-to-Subcutaneous Switch in Rheumatoid Arthritis.","authors":"Theo Wirth, Lisa Diebold, Nathalie Balandraud, Emilie Fockens, Sophie Trijau, Pierre Lafforgue, Thao Pham","doi":"10.3899/jrheum.2026-0406","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0406","url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Mehrdad Shoae Kazemi, Kristýna Bubová, Heřman Mann, Karel Pavelka, Bente Glintborg, Anne Gitte Loft, Helena Santos, Andreas Reich, Anne C Regierer, Jarno Rutanen, Laura Kuusalo, Gary J Macfarlane, Gareth T Jones, Adrian Ciurea, Michael J Nissen, Bjorn Gudbjornsson, Ólafur Pálsson, Žiga Rotar, Katja Perdan Pirkmajer, Catalin Codreanu, Corina Mogosan, Sella Aarrestad Provan, Gunnstein Bakland, Daniela Di Giuseppe, Merete Lund Hetland, Mikkel Østergaard
{"title":"Redefining BASDAI cut-offs in axial spondyloarthritis: implications for patients' eligibility for treatment with biologic disease-modifying antirheumatic drugs.","authors":"Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Mehrdad Shoae Kazemi, Kristýna Bubová, Heřman Mann, Karel Pavelka, Bente Glintborg, Anne Gitte Loft, Helena Santos, Andreas Reich, Anne C Regierer, Jarno Rutanen, Laura Kuusalo, Gary J Macfarlane, Gareth T Jones, Adrian Ciurea, Michael J Nissen, Bjorn Gudbjornsson, Ólafur Pálsson, Žiga Rotar, Katja Perdan Pirkmajer, Catalin Codreanu, Corina Mogosan, Sella Aarrestad Provan, Gunnstein Bakland, Daniela Di Giuseppe, Merete Lund Hetland, Mikkel Østergaard","doi":"10.3899/jrheum.2026-0445","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0445","url":null,"abstract":"<p><strong>Objective: </strong>To compare a newly proposed Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) cut-off for high disease activity (BASDAI≥2.5) with the corresponding Axial Spondyloarthritis Disease Activity Score (ASDAS) cut-off (ASDAS≥2.1) as an eligibility criterion for initiating a biologic disease-modifying antirheumatic drug (bDMARD) in routine care patients with axial spondyloarthritis (axSpA).</p><p><strong>Methods: </strong>Real-world patients with axSpA initiating their first bDMARD from 9 European registries were analysed. Patients were categorised into 4 subgroups according to the fulfilment of ASDAS and BASDAI criteria at baseline, and treatment effect was assessed at 6 months using several response and remission outcomes. Adjusted logistic regression analyses were performed to determine whether fulfilling ASDAS and BASDAI criteria was associated with achieving the treatment outcomes.</p><p><strong>Results: </strong>Of 6,329 patients included, 90.9% fulfilled both ASDAS and BASDAI eligibility criteria at baseline, 2.5% and 2.7% fulfilled either ASDAS or BASDAI criterion alone, while 3.8% fulfilled neither. The subgroup fulfilling both criteria demonstrated the highest responses at 6 months, while the highest remission outcomes were observed in the subgroup fulfilling neither criterion. Fulfilling either criterion at baseline was significantly associated with achieving response outcomes at 6 months, whereas a negative association was observed for remission outcomes.</p><p><strong>Conclusion: </strong>In a multinational European cohort, a very large overlap between the BASDAI and the ASDAS eligibility criteria was shown, and the predictive ability of the two criteria to achieve treatment outcomes was comparable. These findings support the use of BASDAI≥2.5 as a criterion for initiating bDMARD therapy in axSpA, particularly when ASDAS is unavailable.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Selection Collider Bias in Rheumatology.","authors":"Richard J Cook, Jerald F Lawless, Lily Zou","doi":"10.3899/jrheum.2026-0177","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0177","url":null,"abstract":"<p><p>Conditions affecting the selection of individuals for a study are a common source of bias in epidemiological and medical research. A recent trend in epidemiology has been to link selection conditions to the concept of collider variables. The effects of selection and associated collider variables depend on the composition of the study population, the study selection process, the target of inference, and methods of data collection and analysis. We give here an introduction to bias arising from selection effects, termed selection collider bias, and discuss ways of avoiding it. We provide illustrations related to two apparent paradoxes in rheumatology that involve smoking. The first paradox is that smoking, a risk factor for rheumatoid arthritis (RA), appears to be protective for disease progression in RA. The second is that smoking is a risk factor for psoriatic arthritis (PsA), but in some studies involving persons with psoriasis it appears to reduce the risk of PsA. Using data from the Gladman-Krembil Psoriatic Arthritis Research Program we examine the effect of smoking on the development of PsA in individuals with psoriasis and resolve the paradox. collider variables, confounding, directed acyclic graphs, observational data, selection effects.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ilham Ouamer, Samia Belkhadir, Moulay Jihad Berkchi, Lahsen Achemlal
{"title":"An Unusual Presentation of Erythropoietin-Induced Acute Monoarthritis in a Patient With Myelodysplastic Syndrome and Behçet Disease: A Case Report.","authors":"Ilham Ouamer, Samia Belkhadir, Moulay Jihad Berkchi, Lahsen Achemlal","doi":"10.3899/jrheum.2026-0642","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0642","url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond the Total Score: Health Impact Profiles in Axial Spondyloarthritis.","authors":"Olivier Fakih, Vinod Chandran","doi":"10.3899/jrheum.2026-0984","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0984","url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gillian A Hawker, Eric R Bohm, Philippa J A Nicolson, Lissa Pacheco-Brousseau, Lauren K King, Cornelia M Borkhoff
{"title":"Sex Differences in Clinical Need, Willingness, and Surgeon Recommendations for Total Knee Arthroplasty: A Cross-Sectional Study.","authors":"Gillian A Hawker, Eric R Bohm, Philippa J A Nicolson, Lissa Pacheco-Brousseau, Lauren K King, Cornelia M Borkhoff","doi":"10.3899/jrheum.2026-0257","DOIUrl":"10.3899/jrheum.2026-0257","url":null,"abstract":"<p><strong>Objective: </strong>Female individuals experience greater severity of knee osteoarthritis (OA) than their male counterparts but are disproportionately less likely to receive total knee arthroplasty (TKA). We examined whether sex differences in willingness to undergo TKA at surgeon consultation contributed to sex disparities.</p><p><strong>Methods: </strong>This cross-sectional study was nested in a prospective cohort of patients with knee OA referred to Alberta, Canada, hip/knee surgery clinics from 2014 to 2017. A preconsult questionnaire assessed TKA appropriateness and contextual factors. TKA willingness was defined as responding \"yes\" to \"I would definitely consider having TKA now.\" Surgeons reported their TKA recommendation (yes/no) postconsultation. Multivariable logistic regression models examined the association of patient sex with TKA willingness (yes/no) and multivariable log Poisson regression models assessed the association of willingness with receipt of a surgeon recommendation for TKA, stratified by sex. Models were adjusted for TKA appropriateness (need, psychological readiness, expectations, health status) and contextual factors.</p><p><strong>Results: </strong>In total, 2035 participants were included (58.72% female; mean age 65.7 [SD 9.1] years). Adjusting for TKA appropriateness and contextual factors, the odds ratio associated with a female vs a male being \"willing\" was 0.67 (95% CI 0.51-0.88); 1518 (74.59%) participants were recommended TKA. The adjusted risk ratio associated with a \"definitely willing\" individual being recommended TKA was 5.03 (95% CI 3.04-8.33) in male and 2.15 (95% CI 1.68-2.75) in female individuals.</p><p><strong>Conclusion: </strong>Willingness to undergo TKA was associated with a higher likelihood of being recommended for TKA among male individuals than female individuals, raising concerns regarding bias.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149197536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bianca Paulo Correia, Ana Teresa Melo, Oana Moldovan, Raquel Campanilho-Marques
{"title":"Not Just Another Calcinosis Clinical Case.","authors":"Bianca Paulo Correia, Ana Teresa Melo, Oana Moldovan, Raquel Campanilho-Marques","doi":"10.3899/jrheum.2026-0641","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0641","url":null,"abstract":"","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arthur Mageau, Drifa Belhadi, Anne Boutten, Kenza Ouacel, Cedric Laouenan, Evelyne Vinet, Veronique Le Guern, Julie Chezel, Nathalie Morel, Pascale Ghillani-Dalbin, Alexis Mathian, Zahir Amoura, Thomas Papo, Sasha Bernatsky, Nathalie Costedoat-Chalumeau, Karim Sacré
{"title":"Association between NT-proBNP levels and future cardiovascular events in systemic lupus erythematosus: a multicenter longitudinal cohort study.","authors":"Arthur Mageau, Drifa Belhadi, Anne Boutten, Kenza Ouacel, Cedric Laouenan, Evelyne Vinet, Veronique Le Guern, Julie Chezel, Nathalie Morel, Pascale Ghillani-Dalbin, Alexis Mathian, Zahir Amoura, Thomas Papo, Sasha Bernatsky, Nathalie Costedoat-Chalumeau, Karim Sacré","doi":"10.3899/jrheum.2026-0671","DOIUrl":"https://doi.org/10.3899/jrheum.2026-0671","url":null,"abstract":"<p><strong>Objective: </strong>Current strategies for identifying individuals at high risk of cardiovascular events (CVE) in systemic lupus erythematosus (SLE) are lacking. A previous cross-sectional study in SLE showed that NT-proBNP > 133 pg/mL was associated with cardiovascular damage. Our objective was to assess the association between NT-proBNP at a threshold of 133 and incident CVE in SLE.</p><p><strong>Methods: </strong>All SLE patients who were included in the randomised controlled trial PLUS between 2007 and 2010 in France were screened. Patients with a history of CVE, an unavailable serum sample at PLUS inclusion, or incomplete follow-up were excluded from the primary analysis. The primary endpoint was the occurrence of CVE during follow-up.</p><p><strong>Results: </strong>A total of 351 patients (out of 573 included in PLUS) were analyzed. Of these patients, 316 (90.0%) were women with a median age of 38 [30-48] years. Among them, 24 (6.8%) patients experienced at least one CVE that occurred a median of 5 [3-7] years after baseline. Five patients had more than one CVE. In the multivariable analysis, age, dyslipidemia and NT-proBNP were significantly associated with the occurrence of CVE. NT-proBNP was >133pg/mL in 22 (6.3%) patients at baseline. The 133 pg/ml threshold was significantly associated with the occurrence of CVE during follow-up (adjusted hazard ratio [CI 95]: 2.94; 95% CI: 1.12-7.71).</p><p><strong>Conclusion: </strong>A NT-proBNP threshold of 133 pg/ml is associated with future CVE in SLE. SLE care guidelines could consider including NT-proBNP measurement in order to better stratify the cardiovascular prevention strategies in this high-risk population.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}